Medlife Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -153026.71%
- Ebitda 33.47%
- Net Worth -23.34%
- Total Assets 46.13%
About Medlife Formulations
Medlife Formulations Private Limited (MFPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 November 2013 and has a history of 11 years and two months. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Meena Chamaria, Shubhi Chamaria, and Mahesh Chamaria serve as directors at the Company.
Company Details
- LocationNavi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74994MH2013PTC250333
- Company No.
250333
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medlife Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Chamaria  | Director | 23-May-2022 | Current |
| Meena Chamaria | Director | 23-Nov-2013 | Current |
| Shubhi Chamaria | Director | 30-Mar-2019 | Current |
Financial Performance of Medlife Formulations.
Medlife Formulations Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 153026.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medlife Formulations?
In 2020, Medlife Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anuj Printart Private LimitedMeena Chamaria and Shubhi Chamaria are mutual person
- Green Yellow Bio-Energy Private Limited
Mahesh Chamaria is a mutual person
- Ecoflex Packaging Limited
Mahesh Chamaria is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medlife Formulations?
Medlife Formulations has a workforce of 36 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medlife Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlife Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
